Divisions

Our team of skilled professionals delivers customized solutions to address clients' capital requirements, helping them achieve and surpass their objectives.

  • Investment Banking

    We collaborate with both domestic and international companies to offer innovative financing solutions and strategic support while navigating the U.S. Capital Markets.

  • Capital Markets

    We offer our clients tailored solutions, market insight, execution capabilities, investment guidance, and worldwide outreach networks.

  • Wealth Management

    Our Wealth Management division provides personalized financial strategies, including investment advice, retirement planning, and tax optimization, to help clients achieve their long-term financial goals.

  • Research and Strategy

    Our Equity Research division offers research from various industries with detailed insights, recommendations, and forecasts for informed decision-making.

An Ideal Strategic Partner

We strive to be a leading partner and advisor to our clients by enabling them to achieve their strategic goals. We conduct business smarter with flexible and creative solutions that help turn our clients’ ambitions into prosperity.

img

#1

US IPO Issuance in 2022 - 2024 YTD1

img

#1

SPAC Issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

img

Transcontinental Presence

D. Boral Capital offers a unique worldwide footprint with its global bottom-up fundamental institutional relationships.

Distinguished Professionals

Our experienced professionals have completed over 500 transactions and collectively financed over $250B in capital.

Industry Agnostic

We are dedicated to providing solutions to clients across industries: Basic Materials, Energy & Production, Industrials, Financial Services, Consumer, Healthcare, REITs, & Technology.

Recent Transactions
January 16, 2025
img
img
Kairos Pharma, Ltd.
NYSE: KAPA

$3,500,000

Private Placement
Co-Placement Agent

January 14, 2025
img
img
BurTech Acquisition Corp. Merger with Blaize, Inc.
Nasdaq: BZAI

~$894,000,000

Business Combination
Sole Underwriter

January 13, 2025
img
img
Nature’s Miracle Holding, Inc.
Nasdaq: NMHI

$29,700,000

Private Placement
Exclusive Placement Agent

January 6, 2025
img
img
HWH International Inc.
Nasdaq: HWH

$1,765,900

Public Offering
Exclusive Placement Agent

December 30, 2024
img
img
Park Ha Biological Technology Co., Ltd.
Nasdaq: PHH

$4,800,000

Initial Public Offering
Underwriter

December 23, 2024
img
img
FibroBiologics, Inc.
Nasdaq: FBLG

$25,000,000

Private Placement
Exclusive Placement Agent

View All
Insights
  • January 16, 2025

    D. Boral Capital Served as Co-Placement Agent to Kairos Pharma, Ltd. In connection with its $3.5 Million Private Placement

    Read More icon Read More icon
  • January 14, 2025

    D. Boral Capital Served as the Sole Underwriter on the IPO of BurTech Acquisition Corp (Nasdaq: BRKH) which Recently Completed an ~$894 Million Business Combination with Blaize, Inc. (“Blaize”)

    Read More icon Read More icon
  • January 13, 2025

    D. Boral Capital Served as Placement Agent to Nature’s Miracle Holding, Inc. with its up to $29.7 Million Financing

    Read More icon Read More icon
  • January 6, 2025

    D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.